Back
Ligand Pharmaceuticals Vs. Merck & Industry Stock Comparison
Buy
57
LGND
Ligand Pharmaceuticals
Last Price:
105.45
Seasonality Move:
1.98%
Buy
53
MRK
Merck &
Last Price:
116.84
Seasonality Move:
4.08%
Buy
57
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $103.68. The Score for LGND is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Merck & (MRK)
is a Buy
Is Merck & a Buy, Sell or Hold?
- The current Merck & [MRK] share price is $118.64. The Score for MRK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- MRK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $103.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.
MRK Stock Price Chart
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 52.3 | Buy |
| Chaikin Money Flow: | -51724 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.13 - 105.41) | Sell |
| Bollinger Bands (100): | (80.79 - 103.39) | Buy |
MRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 56.08 | Buy |
| Chaikin Money Flow: | 170282 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.67 - 117.79) | Buy |
| Bollinger Bands (100): | (117.16 - 130.46) | Sell |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.52 | Buy |
| 20-day SMA: | 103.99 | Sell |
| 50-day SMA: | 102.51 | Buy |
| 200-day SMA: | 82.41 | Buy |
| 8-day EMA: | 103.75 | Sell |
| 20-day EMA: | 103.37 | Buy |
| 50-day EMA: | 100.17 | Buy |
| 200-day EMA: | 86.03 | Buy |
MRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 116.43 | Buy |
| 20-day SMA: | 116.78 | Buy |
| 50-day SMA: | 118.47 | Buy |
| 200-day SMA: | 122.19 | Sell |
| 8-day EMA: | 117.2 | Buy |
| 20-day EMA: | 116.83 | Buy |
| 50-day EMA: | 118.68 | Sell |
| 200-day EMA: | 119.99 | Sell |
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.72 per share, an increase next quarter of $0.29 per share, an increase this year of $0.04 per share, and an increase next year of $0.86 per share.
Merck & Earnings Growth & MRK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.68 per share, an increase this year of $6.78 per share, and an increase next year of $1.62 per share.
Ligand Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merck & Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||